Repligen (RGEN) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026)
Repligen (RGEN) EPS (Weighted Average and Diluted) Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 31.62% |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -39.68% |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | - |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 20.14% |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.25% |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | - |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -58.74% |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 11.26% |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -32.64% |
| 10 | Repligen | 7.41 Bn | 6.42 Bn | 108.28 Mn | -17.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -17.79% |
| Dec 31, 2025 | -35.32% |
| Sep 30, 2025 | -28.46% |
| Jun 30, 2025 | -33.40% |
| Mar 31, 2025 | -50.21% |
| Dec 31, 2024 | -47.67% |
| Sep 30, 2024 | -26.35% |
| Jun 30, 2024 | -46.14% |
| Mar 31, 2024 | -51.32% |
| Dec 31, 2023 | -40.57% |
| Sep 30, 2023 | 3.57% |
| Jun 30, 2023 | 5.27% |
| Mar 31, 2023 | 14.47% |
| Dec 31, 2022 | 129.85% |
| Sep 30, 2022 | 187.11% |
| Jun 30, 2022 | 72.99% |
| Mar 31, 2022 | 68.27% |
| Dec 31, 2021 | 60.91% |
| Sep 30, 2021 | 79.67% |
| Jun 30, 2021 | 120.13% |